Clinical trial
Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal…
NCT00259298 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00259298 |
|---|---|
| Title | Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis |
| Official title | The Use of Nuclear Scintigraphy to Evaluate the Anabolic Effects of Teriparatide on the Skeleton in Postmenopausal Women With Osteoporosis |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | teriparatide |
| Enrollment | 12 |
| Start date | Nov 1, 2005 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Nov 29, 2005 |
| Last update posted | Aug 11, 2010 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: